Atıf İçin Kopyala
Oruc Z., Kaplan M. A., Geredeli C., Sari N. Y., Ozaslan E., Aytekin A., ...Daha Fazla
JOURNAL OF BUON, cilt.25, sa.2, ss.641-647, 2020 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
25
Sayı:
2
-
Basım Tarihi:
2020
-
Dergi Adı:
JOURNAL OF BUON
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
-
Sayfa Sayıları:
ss.641-647
-
Anahtar Kelimeler:
metastatic breast cancer, eribulin, chemotherapy, prognostic factors, breast cancer, SURVIVAL, EFFICACY, THERAPY, WOMEN, ANTHRACYCLINE, MONOTHERAPY, MESYLATE, SAFETY
-
Marmara Üniversitesi Adresli:
Evet
Özet
Purpose: This study aimed to analyze prognostic factors for survival and the reliability and the effectiveness of eribulin therapy in metastatic breast cancer (MBC) patients.